|Title:||Audit of the appropriate prescribing of Low Molecular Weight Heparin in a busy Regional Hospital|
|Author(s):||A.Rafi, HY Li, NKB Abidin, MK Rana, M Muzammil, S Rizvi|
|Institution:||Mayo University Hospital, Castlebar|
|Poster:||Click to view poster|
|Category:||General Respiratory and Sleep|
|Abstract:||Low molecular weight heparin (LMWH) is a class of anticoagulants that is frequently prescribed in hospitals. Its various indications include Thromboprophylaxis, treatment of DVT/PE, A.Fib and ACS. This audit aimed to assess whether LMWH is prescribed appropriately in this hospital based on Age, Weight and Creatinine Clearance, and according to HSE LMWH prescribing guidelines.|
All patients admitted in the surgical and medical wards of Mayo University hospital between 8th-10th June 2020 were included. Their drug charts were reviewed, documented weights collected and their Creatinine Clearance (CrCl) was calculated according to the Cockcroft-Gault equation.
Out of 128 patients, 67 (52%) patients were on LMWH. Among them, 94% were on Clexane and 6% were on Innohep. 49 (73.1%) patients were appropriately prescribed LMWH and 18 (26.9%) patients were not. Out of those 18 patients, 10 (55.6%) patients were under prescribed and 8 (44.4%) patients were overprescribed. (7 (38.9%) patients were not prescribed according to weight, 3 (16.7%) patients were not prescribed according to CrCl and the remaining 8 (44.4%) patients were prescribed incorrect dose)
These results demonstrate that the majority (73.1%) of patients were prescribed LMWH appropriately. But to achieve maximum compliance and minimise the risk of complications/side effects, on-going education should be provided to NCHDs. Inclusion of the VTE prophylaxis Protocol and specified page for anticoagulation prescription in the hospital’s drug chart would be a useful and safe practice.